CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Deep Brain Stimulation Devices Market by Product (Dual-Channel, Single Channel), Application (Depression, Dystonia, Epilepsy), End-User - Global Forecast 2024-2030
... expected to reach USD 1.76 billion in 2024, at a CAGR 15.06% to reach USD 4.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Deep Brain Stimulation Devices ... Read More
-
Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.42 billion in 2024, at a CAGR 7.62% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Brain Imaging Modalities Market by Imaging Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)), Patient Type (Adults & Paediatrics, Infants), End User - Global Forecast 2024-2030
... size was estimated at USD 14.87 billion in 2023 and expected to reach USD 16.05 billion in 2024, at a CAGR 7.66% to reach USD 24.94 billion by 2030. Global Brain Imaging Modalities Market FPNV ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Asia Pacific Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... (Hospital & Clinics and Ambulatory Surgical Center) The Asia Pacific glioma treatment market is expected to grow from US$ 754.97 million in 2022 to US$ 1,538.88 million by 2030. It is estimated to grow at ... Read More
-
Neurology Endoscopy Devices Market by Product (Accessories, Endoscopes, Operative Devices), Indication (Alzheimer’s Disorders, Brain Cancer, Brain Tumor), Usability, End User, Application - Global Forecast 2024-2030
... 5.19 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.22% to reach USD 8.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in ... Read More
-
Diaphragm Pacing Therapy System Market by Product (Diaphragm Pacemaker, External Diaphragm Pacemaker), Application (Amyotrophic Lateral Sclerosis, Spinal Cord Injury) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.40 billion in 2024, at a CAGR 7.39% to reach USD 8.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in ... Read More
-
South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... End User (Hospital & Clinics and Ambulatory Surgical Center) The South & Central America glioma treatment market is expected to grow from US$ 117.14 million in 2022 to US$ 227.74 million by 2030. It is ... Read More
-
Single Cell Sequencing Market by Product (Consumables, Instruments), Application (Immunology, Microbiology, Neurology), End-User - Global Forecast 2024-2030
... USD 2.64 billion in 2024, at a CAGR 4.87% to reach USD 3.51 billion by 2030. Global Single Cell Sequencing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Single Cell ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Interventional Neurology Devices Market by Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices), End-User (Ambulatory Care Centers, Hospitals, Neurology Clinics) - Global Forecast 2024-2030
... estimated at USD 2.02 billion in 2023 and expected to reach USD 2.17 billion in 2024, at a CAGR 8.97% to reach USD 3.69 billion by 2030. Global Interventional Neurology Devices Market FPNV Positioning Matrix ... Read More
-
Neurology Devices Market by Product (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices), End User (Ambulatory Surgery Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.10 billion in 2024, at a CAGR 7.81% to reach USD 16.03 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurology ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Pediatric Imaging Market by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), Application (Cardiology, Gastroenterology, Neurology), End-User - Global Forecast 2024-2030
... expected to reach USD 38.57 billion in 2024, at a CAGR 8.43% to reach USD 62.77 billion by 2030. Global Pediatric Medical Device Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
Europe Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... & Clinics and Ambulatory Surgical Center) The Europe glioma treatment market is expected to grow from US$ 959.99 million in 2022 to US$ 1,905.10 million by 2030. It is estimated to grow at a CAGR ... Read More
Research Assistance
